Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation

Nat Cancer. 2023 Nov;4(11):1610. doi: 10.1038/s43018-023-00646-4.

Authors

Jennifer Derrien^#¹, Sarah Gastineau^#¹, Antoine Frigout¹, Nils Giordano¹, Mia Cherkaoui¹, Victor Gaborit^{1

2}, Rémi Boinon¹, Elise Douillard^{1

2}, Magali Devic^{1

2}, Florence Magrangeas^{1

2}, Philippe Moreau^{1

3}, Stéphane Minvielle^{1

2}, Cyrille Touzeau^{1

3}, Eric Letouzé^{4

5}

Affiliations

¹ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France.
² University Hospital Hôtel-Dieu, Nantes, France.
³ Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
⁴ Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France. eric.letouze@inserm.fr.
⁵ University Hospital Hôtel-Dieu, Nantes, France. eric.letouze@inserm.fr.

^# Contributed equally.

PMID: 37684528
DOI: 10.1038/s43018-023-00646-4

No abstract available

Publication types

Published Erratum